Effects of trans-10,cis-12 and cis-9,trans-11 CLA on atherosclerosis in apoE/LDLR-/- mice

European Journal of Lipid Science and Technology

Volumn 113, Issue 5, 2011, Pages 572-583

  Kostogrys, Renata B ^a   Maślak, Edyta ^a   Franczyk Zarów, Magdalena ^a   Gajda, Mariusz ^b   Chłopicki, Stefan ^b  

^a UNIVERSITY OF AGRICULTURE IN KRAKOW   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

ApoE LDLR mice; Atherosclerosis; CLA isomers; Liver

Indexed keywords

ANIMALIA; BOVIDAE; MUS;

EID: 79955969431     PISSN: 14387697     EISSN: 14389312     Source Type: Journal    
DOI: 10.1002/ejlt.201000336     Document Type: Article

References (55)

1. Griinari, J. M., Bauman, D. E., in: Yurawecz, M. P., Mossoba, M. M., Kramer, J. K. G., Pariza, M. W., Nelson, G. J. (Eds.), Advances in Conjugated Linoleic Acid Research, AOCS Press, Champaign, IL 1999, pp. 180- 199.
2. Evans, M., Brown, J., McIntosh, M., Isomer-specific effects of conjugated linoleic acid (CLA) on adiposity and lipid metabolism. J. Nutr. Biochem. 2002, 13, 508- 516.
3. Terpstra, A. H., Javadi, M., Beynen, A. C., Kocsis, S., et al., Dietary conjugated linoleic acids as free fatty acids and triacylglycerols similarly affect body composition and energy balance in mice. J. Nutr. 2003, 133, 3181- 3186.
4. Wang, Y., Jones, P. J. H., The role of conjugated linoleic acid in human health. Dietary conjugated linoleic acid and body composition. Am. J. Clin. Nutr. 2004, 79, 1153S- 1158S.
5. Gaullier, J. M., Halse, J., Hoye, K., Kristiansen, K., et al., Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans. J. Nutr. 2005, 135, 778- 784.
6. Belury, M. A., Inhibition of carcinogenesis by conjugated linoleic acid: Potential mechanisms of action. J. Nutr. 2002, 132, 2995- 2998.
7. Field, C. J., Schley, P. D., Evidence for potential mechanisms for the effect of conjugated linoleic acid on tumor metabolism and immune function: Lessons from n-3 fatty acids. Am. J. Clin. Nutr. 2004, 79, 1190S- 1198S.
8. Cho, H. J., Kim, E. J., Lim, S. S., Kim, M. K., et al., Trans-10, cis-12, not cis-9, trans-11, conjugated linoleic acid inhibits G1-S progression in HT-29 human colon cancer cells. J. Nutr. 2006, 136, 893- 898.
9. Kritchevsky, D., Tepper, S. A., Wright, S., Tso, P., Czarnecki, S. K., Influence of conjugated linoleic acid (CLA) on establishment and progression of atherosclerosis in rabbits. J. Am. Coll. Nutr. 2000, 19, 472S- 477S.
10. Kritchevsky, D., Tepper, S. A., Wright, S., Czarnecki, S. K., Influence of graded levels of conjugated linoleic acid (CLA) on experimental atherosclerosis in rabbits. Nutr. Res. 2002, 22, 1275- 1279.
11. Noone, E. J., Roche, H. M., Nugent, A. P., Gibney, M. J., The effect of dietary supplementation using isomeric blends of conjugated linoleic acid on lipid metabolism in healthy human subjects. Br. J. Nutr. 2002, 88, 243- 251.
12. Tricon, S., Burdge, G. C., Kew, S., Banerjee, T., et al., Opposing effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid on blood lipids in healthy humans. Am. J. Clin. Nutr. 2004, 80, 614- 620.
13. Valeille, K., Gripois, D., Blouquit, M. F., Souidi, M., et al., Lipid atherogenic risk markers can be more favourably influenced by the cis-9 trans-11-octadecadienoate isomer than a conjugated linoleic acid mixture or fish oil in hamsters. Br. J. Nutr. 2004, 91, 191- 199.
14. Arbonés-Mainar, J. M., Navarro, M. A., Acín, S., Guzmán, M. A., et al., Trans-10, cis-12- and cis-9, trans-11-conjugated linoleic acid isomers selectively modify HDL-apolipoprotein composition in apolipoprotein E knockout mice. J. Nutr. 2006, 136, 353- 359.
15. Toomey, S., Harhen, B., Roche, H. M., Fitzgerald, D., Belton, O., Profound resolution of early atherosclerosis with conjugated linoleic acid. Atherosclerosis 2006, 187, 40- 49.
16. O'Shea, M., Bassaganya-Riera, J., Mohede, I. C. M., Immunomodulatory properties of conjugated linoleic acid. Am. J. Clin. Nutr. 2004, 79, 1199S- 1206S.
17. Tricon, S., Burdge, G. C., Kew, S., Banerjee, T., et al., Effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid on immune cell function in healthy humans. Am. J. Clin. Nutr. 2004, 80, 1626- 1633.
18. Evans, M., Geigerman, C., Curtis, L., Keubler, B., et al., Trans-10, cis-12 conjugated linoleic acid reduces triglyceride content while differentially affecting pparα2 and ap2 expression in 3t3-l1 preadipocytes. Lipids 2001, 36, 1223- 1232.
19. Jawien, J., Gajda, M., Rudling, M., Mateuszuk, L., et al., Inhibition of five lipoxygenase activating protein (FLAP) by MK-886 decreases atherosclerosis in apoE/LDLR-double knockout mice. Eur. J. Clin. Invest. 2006, 36, 141- 146.
20. Olszanecki, R., Jawien, J., Gajda, M., Mateuszuk, L., et al., Effect of curcumin on atherosclerosis in apoE/LDLR-double knockout mice. J. Physiol. Pharmacol. 2005, 56, 627- 635.
21. Jawien, J., Csanyi, G., Gajda, M., Mateuszuk, L., et al., Ticlopidine attenuates progression of atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice. Eur. J. Pharmacol. 2006, 556, 129- 135.
22. Ishibashi, S., Herz, J., Maeda, N., Goldstein, J. L., Brown, M. S., The two-receptor model of lipoprotein clearance: Tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. Proc. Natl. Acad. Sci. USA 1994, 91, 4431- 4435.
23. Reeves, P. G., Nielsen, F. H., Fahey, G. C., AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad hoc Writing Committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 1993, 123, 1939- 1951.
24. -/-). Br. J. Nutr. 2008, 99, 49- 58.
25. Robertson, A. K., Rudling, M., Zhou, X., Gorelik, L., et al., Disruption of TGF-beta signaling in T cells accelerates atherosclerosis. J. Clin. Invest. 2003, 112, 1342- 1350.
26. Kiernan, J. A., Histological & Histochemical Methods. Theory & Practice, 2nd edition, Pergamon Press, Oxford 1990, pp. 413- 421.
27. Ryder, J. W., Portocarrero, C. P., Song, X. M., et al., Isomer-specific antidiabetic properties of conjugated linoleic acid. Improved glucose tolerance, skeletal muscle insulin action, and UCP-2 gene expression. Diabetes 2001, 50, 1149- 1157.
28. Park, Y., Albright, K. J., Liu, W., Storkson, J. M., et al., Effect of conjugated linoleic acid on body composition in mice. Lipids 1997, 32, 853- 858.
29. Park, Y., Albright, K. J., Storkson, J. M., Liu, W., et al., Changes in body composition in mice during feeding and withdrawal of conjugated linoleic acid. Lipids 1999, 34, 243- 248.
30. West, D. B., Delany, J. P., Camet, P. M., Blohm, F., et al., Effects of conjugated linoleic acid on body fat and energy metabolism in the mouse. Am. J. Physiol. 1998, 275, R667- R672.
31. Park, Y., Pariza, M. W., Mechanisms of body fat modulation by conjugated linoleic acid (CLA). Food Res. Int. 2007, 40, 311- 323.
32. Warren, J. M., Simon, V. A., Bartolini, G., Erickson, K. L., et al., Trans-10, cis-12 CLA increases liver and decreases adipose tissue lipids in mice: Possible roles of specific lipid metabolism genes. Lipids 2003, 38, 497- 504.
33. Ashwell, M. S., Ceddia, R. P., House, R. L., Cassady, J. P., et al., Trans-10, cis-12-conjugated linoleic acid alters hepatic gene expression in a polygenic obese line of mice displaying hepatic lipidosis. J. Nutr. Biochem. 2010, 21, 848- 855.
34. Tsuboyama-Kasaoka, N., Takahashi, M., Tanemura, K., Kim, H. J., et al., Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes 2000, 49, 1534- 1542.
35. Clement, L., Poirier, H., Niot, I., Bocher, V., et al., Dietary trans-10, cis-12 conjugated linoleic acid induces hyperinsulinemia and fatty liver in the mouse. J. Lipid Res. 2002, 43, 1400- 1409.
36. Degrace, P., Demizieux, L., Gresti, J., Chardigny, J. M., et al., Hepatic steatosis is not due to impaired fatty acid oxidation capacities in C57BL/6J mice fed the conjugated trans-10, cis-12-isomer of linoleic acid. J. Nutr. 2004, 134, 861- 867.
37. Belury, M. A., Mahon, A., Banni, S., The conjugated linoleic acid (CLA) isomer, t10, c12-CLA, is inversely associated with changes in body weight and serum leptin in subjects with type 2 diabetes mellitus. J. Nutr. 2003, 133, 257S- 260S.
38. Burdge, G. C., Lupoli, B., Russell, J. J., Tricon, S., et al., Incorporation of cis-9, trans-11 or trans-10, cis-12 conjugated linoleic acid into plasma and cellular lipids in healthy men. J. Lipid Res. 2004, 45, 736- 741.
39. de Deckere, E., van Amelsvoort, J., McNeill, G., Jones, P., Effects of conjugated linoleic acid (CLA) isomers on lipid levels and peroxisome proliferation in the hamster. Br. J. Nutr. 1999, 82, 309- 317.
40. Bee, G., Dietary conjugated linoleic acids alter adipose tissue and milk lipids of pregnant and lactating sows. J. Nutr. 2000, 130, 2292- 2298.
41. Chouinard, P., Courneau, L., Barbano, D., Metzger, L., Bauman, D., Conjugated linoleic acids alter milk fatty acid composition and inhibit milk fat secretion in dairy cows. J. Nutr. 1999, 129, 1579- 1584.
42. Simon, O., Manner, K., Schafer, K., Sagredos, A., Eder, K., Effects of conjugated linoleic acids on protein to fat proportions, fatty acids, and plasma lipids in broilers. Eur. J. Lipid Sci. Technol. 2000, 102, 402- 410.
43. Szymczyk, B., Pisulewski, P. M., Szczurek, W., Hanczakowski, P., The effects of feeding conjugated linoleic acid (CLA) on rat growth performance, serum lipoproteins and subsequent lipid composition of selected rat tissues. J. Sci. Food Agric. 2000, 80, 1553- 1558.
44. Li, Y., Watkins, B. A., Conjugated linoleic acids alter bone fatty acid composition and reduce ex vivo prostaglandin E2 biosynthesis in rats fed n-6 or n-3 fatty acids. Lipids 1998, 33, 417- 425.
45. Munday, J. S., Thompson, K. G., James, K. A. C., Dietary conjugated linoleic acids promote fatty streak formation in the C57BL/6 mouse atherosclerosis model. Br. J. Nutr. 1999, 81, 251- 255.
46. Nestel, P., Fujii, A., Allen, T., The cis-9, trans-11 isomer of conjugated linoleic acid (CLA) lowers plasma triglyceride and raises HDL cholesterol concentrations but does not suppress aortic atherosclerosis in diabetic apoE-deficient mice. Atherosclerosis 2006, 189, 282- 287.
47. -/- mice fed a high-cholesterol diet. Atherosclerosis 2008, 200, 294- 302.
48. Yotosumoto, H., Hara, E., Naka, S., 10 trans, 12 cis linoleic acid reduces apolipoprotein B secretion in HepG2 cells. Food Res. Int. 1999, 31, 403- 409.
49. Grundy, S. M., Denke, M. A., Dietary influences on serum lipids and lipoproteins. J. Lipid Res. 1990, 31, 1149- 1172.
50. Yeung, Ch. H. T., Yang, L., Huang, Y., Wang, J., et al. Dietary conjugated linoleic acid mixture affects the activity of intestinal acyl coenzyme A: Cholesterol acyltransferase in hamsters. Br. J. Nutr. 2000, 84, 935- 941.
51. Fernandez, M. L., West, K. L., Mechanisms by which dietary fatty acids modulate plasma lipids. J. Nutr. 2005, 135, 2075- 2078.
52. Gonzalez, F. J., Animal models for human risk assessment: The peroxisome proliferator-activated receptor alpha-humanized mouse. Nutr. Rev. 2007, 65, S2- S6.
53. Belury, M. A., Moya-Camarena, S. Y., Liu, K. L., Vander Heuvel, J. P., Dietary conjugated linoleic acid induces peroxisome-specific enzyme accumulation and ornithine decarboxylase activity in mouse liver. J. Nutr. Biochem. 1997, 8, 579- 584.
54. Rasooly, R., Kelley, D. S., Greg, J., Mackey, B. E., Dietary trans 10, cis 12-conjugated linoleic acid reduces the expression of fatty acid oxidation and drug detoxification enzymes in mouse liver. Br. J. Nutr. 2007, 97, 58- 66.
55. Mitchell, P. L., McLeod, R. S., Conjugated linoleic acid and atherosclerosis: Studies in animal models. Biochem. Cell Biol. 2008, 86, 293- 301.